ArticleBMC urology2025
BlaCancer: a mobile health solution for enhancing bladder cancer care.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Knowledge, attitudes, and practices related to health management among patients receiving intravesical instillation.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundBladder cancer (BC) ranks among the most prevalent ten cancers globally. Current management for BC has seen limited innovation, particularly for advanced stages. Mobile health (mHealth) technologies offer an opportunity to improve BC management by engaging, educating, and empowering patients and assisting physicians, yet available apps are insufficient.
objectiveThe goal of this study was to provide guidance for designing 'BlaCancer', a mobile app that addresses unfulfilled needs in BC care. We conducted cross-sectional surveys with 16 BC patients and 28 physicians to determine their needs for an mHealth solution.
resultsPatients perceived their levele of understanding of BC as moderate (mean score: 4.75/7), and 68.8% supported mobile apps for education, medical records, and peer support. Physicians stressed the significance of treatment recommendations (89.3%), symptom recording (39.3%), and decision-making tools. Other concerns included data privacy and integration issues.
conclusion'BlaCancer' uses stakeholder input to deliver education, symptom monitoring, and clinical decision assistance. The software intends to increase patient participation, improve communication, and streamline aspects of BC care. The small sample size is a limitation that affects generalizability, but the findings still highlight opinions from physicians and patients regarding the role of an app for BC care. Future research will assess the influence on clinical outcomes and quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.